Catalyst Wire Dossier Catalyst Wire Dossier

MEHD7945A

MEHD7945A · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MEHD7945A, covering 2016-07-18 to 2018-05-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors [Phase 1]

See pricing